The aim of this paper is to determine how genetic predisposition to thrombophilia—specifically, the heterozygous or homozygous states of FVL and prothrombin, as well as levels of PC, PS, and AT—affects the etiology of ischemic strokes in young individuals. The gene discussed is F2; the disease is Rare hereditary thrombophilia.